A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma.
暂无分享,去创建一个
R. Greil | M. Mayerhoefer | P. Neumeister | M. Raderer | T. Melchardt | I. Simonitsch-Klupp | W. Willenbacher | A. Egle | B. Kiesewetter | E. Willenbacher | D. Voskova